Summary Company Announcement Date: December 16, 2024 FDA Publish Date: December 18, 2024 Product Type: Drugs Reason for Announcement: Recall Reason Description Product contains undeclared Metformin and Glyburide Company Name: Shoppers-Plaza Brand Name: Brand Name(s) Product Description: Product Description SugarLin Herbal Formula Herbal Dietary Supplement Company Announcement FOR IMMEDIATE RELEASE – December 16, 2024 –…
Implantable Marker Recall: Hologic Removes BioZorb 3D Bioabsorbable Markers due to Risk for Patient Complications
This recall involves removing devices from where they are used or sold. The FDA has identified this recall as the most serious type. This device may cause serious injury or death if you continue to use it. Affected Product Product Names: BioZorb Marker and BioZorb LP Marker Product Codes: NEU Product Part Numbers: F0405 BioZorb…
Accolade Pacemaker Devices by Boston Scientific and Potential Need for Early Device Replacement – FDA Safety Communication
Date Issued: December 16, 2024 The U.S. Food and Drug Administration (FDA) is alerting patients, caregivers, and health care providers about the potential need for early device replacement of Boston Scientific Corporation (Boston Scientific) Accolade pacemaker devices, which includes the Accolade, Proponent, Essentio, and Altrua 2 Standard Life (SL) and Extended Life (EL) pacemakers, and…
Buy-herbal.com Issues Voluntary Nationwide Recall of Nhan Sam Tuyet Lien Truy Phong Hoan Capsules Due to Undeclared Furosemide, Dexamethasone and Chlorpheniramine
Summary Company Announcement Date: December 12, 2024 FDA Publish Date: December 13, 2024 Product Type: Drugs Reason for Announcement: Recall Reason Description Device & Drug Safety – Unapproved Drug Company Name: Buy-herbal.com Brand Name: Brand Name(s) Buy-herbal.com Product Description: Product Description Nhan Sam Tuyet Lien Truy Phong Hoan dietary supplement capsules Company Announcement FOR IMMEDIATE…
Ocaliva (obeticholic acid) by Intercept Pharmaceuticals: Drug Safety Communication – Serious Liver Injury Being Observed in Patients without Cirrhosis
[12/12/2024] AUDIENCE: Gastroenterology, Hepatology, Patient, Health Care Professional, Pharmacy ISSUE: The FDA identified cases of serious liver injury among patients being treated for primary biliary cholangitis (PBC) with Ocaliva (obeticholic acid) who did not have cirrhosis of the liver. The original clinical trial showed a decrease in alkaline phosphatase (ALP) that supported FDA accelerated approval….
Skip the Antibacterial Soap; Use Plain Soap and Water
Image Español When you buy soaps and body washes, do you reach for products labeled “antibacterial” hoping they’ll keep your family safer? Do you think those products will lower your risk of getting sick, spreading germs or being infected? According to the U.S. Food and Drug Administration, currently there isn’t sufficient evidence to show that…
Early Alert: Infusion Pump Issue from Fresenius Kabi USA
This communication is part of the Communications Pilot to Enhance the Medical Device Recall Program. The FDA has become aware of a potentially high-risk device issue. The FDA will keep the public informed and update this web page as significant new information becomes available. Affected Product The FDA is aware that Fresenius Kabi USA has…
Neonatal Incubator Correction: GE HealthCare Updates Use Instructions for GE HealthCare Giraffe OmniBed Carestation and Incubator Carestation due to Risk of Patient Formaldehyde Exposure
The devices described in this recall are the same devices announced in the related Letter to Health Care Providers. On November 8, 2024 the FDA issued an update to the Letter to Health Care Providers to provide the most recent recommendations provided by GE HealthCare. This recall involves updating instructions for using devices, and does…
Syringe Recall: Cardinal Health Removes Certain Monoject U-100 mL Insulin Syringe Luer Lock with Tip Cap Soft Packs due to Incompatibility with Needleless Connectors
This recall involves removing certain devices from where they are used or sold. The FDA has identified this recall as the most serious type. This device may cause serious injury or death if you continue to use it. Affected Product Product Names: Monoject U-100 mL Insulin Syringe Luer Lock with Tip Cap Soft Pack (extended…
Peritoneal Dialysis Set Correction: Baxter Issues Correction for MiniCap Extended Life Peritoneal Dialysis Transfer Sets Due to Risk of Patient Exposure to Higher Than Allowable Levels of Toxic Compound NDL-PCBA and/or NDL-PCBs
This recall involves correcting certain devices, and does not involve removing them from where they are used or sold. The FDA has identified this recall as the most serious type. This device may cause serious injury or death if you continue to use it without correction. Affected Product Product Name: MiniCap Extended Life PD Transfer…